PubMed for id: 341018

Year	Number of Results
2008	1
2009	1
2010	1
2011	2
2012	2
2013	3
2014	2
2015	7
2016	4
2024	0

1

Understanding transport by the major facilitator superfamily (MFS): structures pave the way.

Quistgaard EM, Löw C, Guettou F, Nordlund P. Quistgaard EM, et al. Nat Rev Mol Cell Biol. 2016 Feb;17(2):123-32. doi: 10.1038/nrm.2015.25. Epub 2016 Jan 13. Nat Rev Mol Cell Biol. 2016. PMID: 26758938 Review.

2

Prostate cancer: SLCO2B1 variants correlate with castration resistance.

Sidaway P. Sidaway P. Nat Rev Urol. 2016 Feb;13(2):65. doi: 10.1038/nrurol.2015.306. Epub 2015 Dec 31. Nat Rev Urol. 2016. PMID: 26718456 No abstract available.

3

Association of SLCO2B1 Genotypes With Time to Progression and Overall Survival in Patients Receiving Androgen-Deprivation Therapy for Prostate Cancer.

Wang X, Harshman LC, Xie W, Nakabayashi M, Qu F, Pomerantz MM, Lee GS, Kantoff PW. Wang X, et al. J Clin Oncol. 2016 Feb 1;34(4):352-9. doi: 10.1200/JCO.2015.62.5988. Epub 2015 Dec 14. J Clin Oncol. 2016. PMID: 26668348 Free PMC article.

4

Organic Anion Transporting Polypeptide (OATP)2B1 Contributes to Gastrointestinal Toxicity of Anticancer Drug SN-38, Active Metabolite of Irinotecan Hydrochloride.

Fujita D, Saito Y, Nakanishi T, Tamai I. Fujita D, et al. Drug Metab Dispos. 2016 Jan;44(1):1-7. doi: 10.1124/dmd.115.066712. Epub 2015 Nov 2. Drug Metab Dispos. 2016. PMID: 26526067

5

Energy coupling mechanisms of MFS transporters.

Zhang XC, Zhao Y, Heng J, Jiang D. Zhang XC, et al. Protein Sci. 2015 Oct;24(10):1560-79. doi: 10.1002/pro.2759. Epub 2015 Sep 18. Protein Sci. 2015. PMID: 26234418 Free PMC article. Review.

6

Structural Biology of the Major Facilitator Superfamily Transporters.

Yan N. Yan N. Annu Rev Biophys. 2015;44:257-83. doi: 10.1146/annurev-biophys-060414-033901. Annu Rev Biophys. 2015. PMID: 26098515 Review.

7

Expression of OATP2B1 as determinant of drug effects in the microcompartment of the coronary artery.

Hussner J, Begunk R, Boettcher K, Gliesche DG, Prestin K, Meyer Zu Schwabedissen HE. Hussner J, et al. Vascul Pharmacol. 2015 Sep;72:25-34. doi: 10.1016/j.vph.2015.06.006. Epub 2015 Jun 16. Vascul Pharmacol. 2015. PMID: 26091578

8

Organic anion transporting polypeptide 2B1 expression correlates with uptake of estrone-3-sulfate and cell proliferation in estrogen receptor-positive breast cancer cells.

Matsumoto J, Ariyoshi N, Sakakibara M, Nakanishi T, Okubo Y, Shiina N, Fujisaki K, Nagashima T, Nakatani Y, Tamai I, Yamada H, Takeda H, Ishii I. Matsumoto J, et al. Drug Metab Pharmacokinet. 2015 Apr;30(2):133-41. doi: 10.1016/j.dmpk.2014.10.005. Epub 2014 Nov 14. Drug Metab Pharmacokinet. 2015. PMID: 25857231

9

SLCO1B1, SLCO2B1, and SLCO1B3 polymorphisms and susceptibility to bladder cancer risk.

Bui HT, Fujimoto N, Kubo T, Inatomi H, Matsumoto T. Bui HT, et al. Cancer Invest. 2014 Jul;32(6):256-61. doi: 10.3109/07357907.2014.907421. Epub 2014 Apr 24. Cancer Invest. 2014. PMID: 24762081

10

Effects of polymorphisms of the SLCO2B1 transporter gene on the pharmacokinetics of montelukast in humans.

Kim KA, Lee HM, Joo HJ, Park IB, Park JY. Kim KA, et al. J Clin Pharmacol. 2013 Nov;53(11):1186-93. doi: 10.1002/jcph.144. Epub 2013 Aug 23. J Clin Pharmacol. 2013. PMID: 23970434

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

17 results

Results by year